Biopac India Corporation Ltd. announced audited standalone earnings results for the fourth quarter and year ended March 31, 2017. For the quarter, the company reported net sales/income from operations of INR 138.765 million against INR 124.800 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 11.469 million against INR 3.470 million a year ago. Profit from ordinary activities before tax was INR 0.330 million against loss of INR 6.078 million a year ago. Net loss was INR 0.489 million or INR 0.03 per basic and diluted share before and after extraordinary items against INR 6.165 million or INR 0.36 per basic and diluted share before and after extraordinary items a year ago. For the year, the company reported net sales/income from operations of INR 477.723 million against INR 520.969 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 45.418 million against INR 46.035 million a year ago. Profit from ordinary activities before tax was INR 2.799 million against INR 7.477 million a year ago. Net profit was INR 0.983 million or INR 0.06 per basic and diluted share before and after extraordinary items against INR 0.519 million or INR 0.03 per basic and diluted share before and after extraordinary items a year ago.